A lab led by attention-mechanism pioneer Kyunghyun Cho has a $500M commitment to build one foundation model spanning biology, clinical…
DeepTek is cutting the price of its chest X-ray AI to about a third for public and non-profit providers across…
The Shanghai biotech won clearance for NTS231, a compound aimed at a protein that helps tumors survive treatment.
The AI drug discovery firm filed an IND for a pain candidate built to act inside the gut and stay…
Tempus won clearance for software that reads a routine heart tracing for signs of undiagnosed mitral regurgitation.
CapsoVision's software won FDA clearance to mark suspicious images in small-bowel capsule studies and cut review time.
Sweden's largest county will let software read screening mammograms on its own, taking a seat normally held by a specialist.
Roche told investors it wants research that needs fewer hands on deck, an ambition the company frames as AI independence.